When James Choate-Deeds was diagnosed with prostate cancer, he joined a clinical trial for robotic-assisted surgery, which was approved by the FDA in 2025.

Scientists warn that rapid advances in AI and neurotechnology are outpacing our understanding of consciousness, creating serious ethical risks. New research contends that developing scientific tests ...

Black doctors faced systematic exclusion from many American healthcare institutions, despite playing a crucial role in medical breakthroughs ...

The quick evolution of technology will lead to continued innovations in patient care, according to Barry Lyon, DDS. Dr. Lyon, dental director for Main Street Children’s Dentistry and Orthodontics and ...

Cell and gene therapies, or CGT, have come a long way since they were first introduced. In the last few decades, both cell therapy—the transplantation of living cells—and gene therapy—the use of ...

Medtronic (NYSE:MDT) announced today that it received FDA clearance for its Stealth AXiS robotic system for spine surgery.

In season two of the five-time Emmy winning medical drama, a new attending physician, Baran Al-Hashimi (Sepideh Moafi), is determined to improve efficiencies at the hospital. She tells her skeptical ...

A child with a new cochlear implant works on auditory rehabilitation exercises at home in Toulouse, France, aided by Pepper, ...

TUMBLER RIDGE, British Columbia (AP) — The father of a 12-year-old victim of the mass shooting in a remote Canadian town ...

From the first successful kidney transplant in 1954, modern organ transplantation has often been linked to the horrors of Frankenstein. While people have grown to accept kidney and liver transplants ...

Drugmaker Novartis’ Super Bowl ad explained that prostate cancer screening starts with a simple blood test, aiming to dispel fear of an exam for a treatable cancer.

Higher education as we know it is on the verge of becoming obsolete,” the former Google AI leader told Fortune.